Eleni V. Dimaraki

Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant

Peter Trainer, William M Drake, Laurence Katznelson et al. · New England Journal of Medicine · 2000 · 875 citations · Full text

Pharmacy, Endocrinology, Pharmacotherapy +12

Acromegaly with Apparently Normal GH Secretion: Implications for Diagnosis and Follow-Up

Eleni V. Dimaraki, Craig A. Jaffe, Roberta DeMott-Friberg et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 219 citations

Medicine, Endocrinology, Autoimmunity +10

Ghrelin Secretion in Humans Is Sexually Dimorphic, Suppressed by Somatostatin, and Not Affected by the Ambient Growth Hormone Levels

Ariel L. Barkan, Eleni V. Dimaraki, Stacy K. Jessup et al. · The Journal of Clinical Endocrinology & Metabolism · 2003 · 213 citations · Full text

Life Sciences, Endocrinology, Physiology +17

Cardiovascular Risk Factors in Acromegaly before and after Normalization of Serum IGF-I Levels with the GH Antagonist Pegvisomant

Gemma Sesmilo, Wesley P. Fairfield, Laurence Katznelson et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 112 citations

Medicine, Endocrinology, Pharmacology +8

Clinically Silent Somatotropinomas May Be Biochemically Active

A. A. Sakharova, Eleni V. Dimaraki, William F. Chandler et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 62 citations · Full text

Medicine, Endocrinology, Autoimmunity +7